Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tenet Healthcare (THC) and Galapagos (GLPG).
Tenet Healthcare (THC)
In a report released today, John Ransom from Raymond James reiterated a Buy rating on Tenet Healthcare, with a price target of $55.00. The company’s shares closed last Thursday at $42.03.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 12.4% and a 64.9% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, AmerisourceBergen, and Oak Street Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $33.67 average price target.
See today’s analyst top recommended stocks >>
In a report released today, Dane Leone from Raymond James maintained a Hold rating on Galapagos. The company’s shares closed last Thursday at $118.84, close to its 52-week low of $112.00.
According to TipRanks.com, Leone is a 5-star analyst with an average return of 17.2% and a 65.7% success rate. Leone covers the Healthcare sector, focusing on stocks such as Lineage Cell Therapeutics, Adverum Biotechnologies, and Tarsus Pharmaceuticals.
The word on The Street in general, suggests a Hold analyst consensus rating for Galapagos with a $141.54 average price target, a 19.4% upside from current levels. In a report issued on November 25, RBC Capital also maintained a Hold rating on the stock with a $127.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.